Relapsing Multiple Sclerosis (RMS) Not Yet Recruiting Phase 2 Trials for Interferon beta-1a (DB00060)

Also known as: Multiple Sclerosis Relapse / Relapsed Multiple sclerosis / Relapsing Multiple Sclerosis / Multiple sclerosis flare

IndicationStatusPhase
DBCOND0044896 (Relapsing Multiple Sclerosis (RMS))Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04079088Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) in Relapsing Multiple Sclerosis (RMS)Treatment